Skip to content

Efficacy of repetitive transcranial magnetic stimulation combined with pelvic floor magnetic stimulation on postpartum women with pelvic floor muscle hypertonia

Efficacy of repetitive transcranial magnetic stimulation combined with pelvic floor magnetic stimulation on postpartum women with pelvic floor muscle hypertonia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094185
Enrollment
Unknown
Registered
2024-12-18
Start date
2024-12-20
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic floor muscle hypertonia

Interventions

Interventional group:rTMS+PFMS
Control group:Sham rTMS+PFMS

Sponsors

The Fourth Affiliated Hospital of Soochow University ( Suzhou Dushu Lake Hospital )
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) 42 days to 12 months postpartum; (2) Age: 20-40 years old; (3) Pelvic floor surface electromyography assessment showed that there was an increase in the resting potential of the pelvic floor muscles (anterior and posterior resting potentials >4µV), and there was myofascial tenderness or pain trigger point on finger-vaginal palpation of the pelvic floor muscles; (4) not receiving other pelvic floor therapy within 3 months prior to the start of the trial; (5) Voluntarily participate in this clinical trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) TMS contraindication due to acute systemic or intracranial hemorrhagic disorder; (2) with a metal heart valve or pacemaker; (3) Acute genital tract inflammation or bleeding tendency; (4) Severe heart disease, hypertension or severe heart, liver, lung and kidney dysfunction; (5) persons using implanted electronic devices; (6) Have intracranial infection/tumor; (7) Intracranial vascular metal stent implantation; (8) accompanied by fever; (9) History of pelvic floor surgery other than childbirth; (10) Adverse reactions to magnetotherapy; (11) There is an open wound or infection at the treatment site; (12) Have malignant pleural effusion, active tuberculosis or cancer; (13) Have a serious mental illness or epilepsy; (14) Pregnancy or short-term (3 months) to get pregnant.

Design outcomes

Primary

MeasureTime frame
Pelvic floor myofascial tenderness VAS score;Glazer evaluation of pelvic floor surface electromyography;

Secondary

MeasureTime frame
Modified Oxford Strength Grading ( MOS score );Female Sexual Function Index ( CVFSFI );Self Rating Depression (SDS);Pelvic floor four-dimensional superindex;Cerebral blood oxygen data(fNIRS);Pivotal indicators(TMS);Self Rating Anxiety (SAS);

Countries

China

Contacts

Public ContactMin Su

The Fourth Affiliated Hospital of Soochow University ( Suzhou Dushu Lake Hospital )

sumin@suda.edu.cn+86 130 3105 6155

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026